Skip to main content
OpenTrials

Clinical trial condition

Stomach Neoplasms

Explore clinical trials studying Stomach Neoplasms. Study availability and eligibility vary by location and protocol.

1,999 public trials 495 recruiting studies
Refine in advanced search Browse all conditions

Stomach Neoplasms trial results

Completed

Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma

NCT00737438

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +10 more
Locations
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center Commack, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Memorial Sloan Kettering Cancer Center Rockville Centre, New York, United States
View Trial Details
Completed

No Antimicrobial Prophylaxis for Laparoscopic Distal Gastrectomy

NCT02200315

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +11 more
Locations
  • Chonnam National University Hwasun Hospital Hwasun-eup, Jeollanam-do, South Korea
  • Dong-A University Hospital Busan, Kyungsang-do, South Korea
  • Kyemyung University Dongsan Medical Center Daegu, Kyungsang-do, South Korea
View Trial Details
Completed

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

NCT00526669

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +10 more
Locations
  • GSK Investigational Site Loma Linda, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Washington D.C., District of Columbia, United States
  • GSK Investigational Site Shreveport, Louisiana, United States
View all 22 locations
View Trial Details
Completed

Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer

NCT00982592

Conditions
Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Digestive System Diseases, +12 more
Locations
  • University of California at Davis Cancer Center Sacramento, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Cancer Care Center of Decatur Decatur, Illinois, United States
  • Decatur Memorial Hospital Decatur, Illinois, United States
View all 30 locations
View Trial Details
Completed

Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer

NCT01260701

Conditions
Adenocarcinoma of the Gastroesophageal Junction, Diffuse Gastric Adenocarcinoma, Digestive System Diseases, +10 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • The University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
  • The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 187 locations
View Trial Details
Completed

Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors

NCT00515216

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details

Related conditions